DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Sutherland RL. Musgrove EA.
CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease.
Breast Cancer Res 2009;
11
DOI: 10.1186/bcr2454.
We do not assume any responsibility for the contents of the web pages of other providers.